Why don’t most men consider prevention?

There are a couple of interesting new commentaries that discuss the idea of using 5α-reductase inhibitors to prevent prostate cancer (and other agents to prevent breast cancer). … READ MORE …

Who should receive a 5-ARI to prevent prostate cancer?

The “New” Prostate Cancer InfoLink has long argued that the potential of 5α-reductase inhibition (using finasteride and dutasteride) to prevent prostate cancer is under-appreciated and under-utilized. However, we also acknowledge a lack of good data to identify those patients for whom the benefits of prevention may outweigh the risks associated with the side effects of such treatment. … READ MORE …

Experts discuss prostate cancer prevention

Several experts discussed current issues related to prostate cancer prevention at the annual winter meeting of the Society for Urologic Oncology in Bethesda, MD, this week. … READ MORE …

“Heavy” drinking, finasteride, and prostate cancer risk

Many men wouldn’t think that drinking four beers over the course of a Sunday afternoon football game was “any big deal” — but maybe it’s a habit one doesn’t want to get into on a daily basis. … READ MORE …

Prostate cancer news reports: Thursday, July 9, 2009

Today’s news reports address such items as:

  • Finasteride in the prevention of prostate cancer
  • Nitric oxide treatment in men with a rising PSA after first-line therapy
  • Decreased use of LHRH agonist therapy since 2003 … READ MORE …

Not much to look out for at AACR and ASCO!

The annual meeting of the American Association for Cancer Research starts tomorrow in Denver, Colorado. … READ MORE …

The Thursday news reports: March 26, 2009

This morning’s news report addresses items on:

  • p53 overexpression and prostate cancer outcomes
  • Diet and prostate cancer in newly diagnosed patients and prostate cancer survivors
  • Outcomes of surgical treatment of men with clinical T1a and T1b disease
  • Peripheral androgen ablation in men with biochemical recurrence after first-line treatment … READ MORE …

The AUA and ASCO jointly issue guideline on use of 5-ARIs to prevent prostate cancer

The “New” Prostate Cancer InfoLink is delighted to report that a joint ASCO/AUA task force has just issued a new set of guidelines recommending discussion between doctors and their patients about the potential use of 5α-reductase inhibitors (5-ARIs) such as finasteride or dutasteride as agents to reduce the risk of prostate cancer. … READ MORE …

The Friday prostate cancer news reports: January 30, 2009

Today’s news reports are focused on issued around epidemiology, prevention, diagnosis, treatment decisions, and the role of humor in prostate cancer support group interactions. … READ MORE …

Finasteride in the prevention of prostate cancer (yet again)

A “Beyond the Abstract” article on UroToday has again raised the issue of the appropriateness of finasteride as a suitable agent for the prevention of prostate cancer in appropriately selected men known to be at significant risk for this disease. … READ MORE …

ASCO highlights three advances in prostate cancer in 2008

Each year the American Society for Clinical Oncology (ASCO) highlights the major advances made in the prevention and management of cancer (click here for the full text). Three advances made the list for prostate cancer in 2008 … but almost no one is acting on one of the most important of these! … READ MORE …

The weekend prostate cancer news: October 25, 2008

Some interesting new reports today include:

  • An update on the Prostate Cancer Prevention Trial
  • Early data on the potential of a traditional Chinese herbal medication
  • Predictive value of PSA velocity in management of low-risk patients with low-dose brachytherapy
  • Reviews of emerging biomarkers and the role(s) of MRI … READ MORE …